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Abstract
The rabbit is a classical experimental animal species. A major limitation in using rabbits for biomedical research
is the lack of germ-line-competent rabbit embryonic stem cells (rbESCs). We hypothesized that the use of
homologous feeder cells and recombinant rabbit leukemia inhibitory factor (rbLIF) might improve the chance in
deriving germ-line-competent rbES cells. In the present study, we established rabbit embryonic fibroblast (REF)
feeder layers and synthesized recombinant rbLIF. We derived a total of seven putative rbESC lines, of which two
lines (M5 and M23) were from culture Condition I using mouse embryonic fibroblasts (MEFs) as feeders
supplemented with human LIF (hLIF) (MEF + hLIF). Another five lines (R4, R9, R15, R21, and R31) were derived
from Condition II using REFs as feeder cells supplemented with rbLIF (REF + rbLIF). Similar derivation effi-
ciency was observed between these two conditions (8.7% vs. 10.2%). In a separate experiment with 2 · 3 factorial
design, we examined the effects of feeder cells (MEF vs. REF) and LIFs (mLIF, hLIF vs. rbLIF) on rbESC culture.
Both Conditions I and II supported satisfactory rbESC culture, with similar or better population doubling time
and colony-forming efficiency than other combinations of feeder cells with LIFs. Rabbit ESCs derived and
maintained on both conditions displayed typical ESC characteristics, including ESC pluripotency marker ex-
pression (AP, Oct4, Sox2, Nanog, and SSEA4) and gene expression (Oct4, Sox2, Nanog, c-Myc, Klf4, and Dppa5),
and the capacity to differentiate into three primary germ layers in vitro. The present work is the first attempt to
establish rbESC lines using homologous feeder cells and recombinant rbLIF, by which the rbESCs were derived
and maintained normally. These cell lines are unique resources and may facilitate the derivation of germ-
line-competent rbESCs.
Introduction
Mammalian embryonic stem cells (ESCs) are plurip-otent cells derived from the inner cell mass (ICM) of
blastocysts (Evans and Kaufman, 1981; Martin, 1981; Thom-
son et al., 1998). These cells are characterized by unlimited
self-renewal and the ability to undergo differentiation into all
cell lineages, such as cardiomyocytes (Doss et al., 2008), he-
patocytes (Ochiya et al., 2010), adipocytes (Chen et al., 2007),
and germ cells (Zhou et al., 2010), making them an attractive
resource for the generation of cells that could be used for cell-
based transplantation therapies (Intawicha et al., 2009; Vo-
larevic et al., 2011). The ability to maintain ESCs in long-term
culture provides a time window to modify the genome of
these cells by homologous recombination (HR) (e.g., gene
knockout). Genetically modified cells can then be injected into
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a blastocyst to generate chimeric offspring in animal research
(Gama Sosa et al., 2010). If the ESCs are germ-line competent
(i.e., contributing to the germ-line cells), transgenic animals
can be produced via this approach.
The rabbit is a classical model animal species (Fan and
Watanabe, 2003; Intawicha et al., 2009; Lin et al., 2011). It has
a short gestation period (30–31 days), large litter size (4–12/
litter), and can be housed conveniently in an indoor facility.
Compared to mice, rabbits are phylogenetically closer to
humans (Fan and Watanabe, 2003). Because of the anatom-
ical, physiological, genetic, and biochemical similarities be-
tween the rabbit and the human, this species is preferentially
used in pulmonary, cardiovascular, and metabolic studies
(Fan and Watanabe, 2003).
ESC technology has developed dramatically in the past
decade. Stable ESC lines have been established in many
mammalian species, including mouse (Evans and Kaufman,
1981), rat (Buehr et al., 2008; Li et al., 2008), monkey (Takada
et al., 2002; Thomson et al., 1995), dog (Vaags et al., 2009),
cattle (Wang et al., 2005), and human (Thomson et al., 1998).
Despite all of these achievements and efforts, only murine
and rat ESCs have successfully transmitted to the germ line
(Buehr et al., 2008; Evans and Kaufman, 1981; Li et al., 2008).
The lack of germ-line-competent rabbit ESCs (rbESCs) has
been recognized as a major limitation in using rabbits for
biomedical research and production (Fang et al., 2006;
Graves and Moreadith, 1993; Honda et al., 2008; Intawicha
et al., 2009; Wang et al., 2007). There is a need to optimize
current derivation and culture procedures for rbESCs so that
the qualities of the cells can be improved, with an ultimate
goal to accomplish germ-line transmission.
The application of feeder cells and leukemia inhibitory
factor (LIF), both of which are of mouse origin, is considered
to be the technical breakthrough in establishing authentic
murine ES cells (Evans and Kaufman, 1981; Martin, 1981;
Pease et al., 1990). Besides mouse, homologous feeder cells
were reported to support the establishment and culture of
human and monkey ESCs, with similar characteristics of
those cultured on mouse embryonic fibroblasts (MEFs) (Li
et al., 2005; Richards et al., 2002). Recently, a study on cat
ESCs (cESC) revealed that homologous feeder cells provided
better cell support for the initial attachment of ICMs, gen-
erated higher number of cESCs, and maintained these cells in
the undifferentiated status longer than MEF cells did (Gomez
et al., 2010). Similar findings were reported in buffalo ESC
derivation (Kumar et al., 2011). On the other hand, it is
known that human leukemia inhibitory factor (hLIF) binds to
both human and mouse LIF receptors (LIFRs), whereas mLIF
binds only to mouse but not human LIFRs (Owczarek et al.,
1997), suggesting differential cross-reactivity and respon-
siveness of ESCs to LIF of different species origins. However,
although mLIF has been utilized on rbESC studies (In-
tawicha et al., 2009), the effect of rbLIF on rbESC derivation
has not been examined.
Pluripotent rbESC lines were established more than 10
years ago (Graves and Moreadith, 1993), but there has been
no report on successful derivation and maintenance of rbESC
lines using rabbit embryonic fibroblasts (REFs) or rabbit LIF
(rbLIF). Previously, most rbESC lines were established on
MEFs in the presence of mLIF or hLIF (Fang et al., 2006;
Graves and Moreadith, 1993; Honda et al., 2008; Intawicha
et al., 2009; Wang et al., 2007). These rbESC lines were de-
rived from fertilized, parthenogenetically activated, as well
as cloned embryos. Most of these cell lines were capable of
self-renewal, remained undifferentiated in culture, formed
embryoid bodies (EBs) containing all three primary germ
layers upon induction, and generated positive teratomas af-
ter transferring to immunocompromised mice. Following
injection into blastocysts and embryo transfer, some of these
rbESCs formed coat color chimeras; unfortunately none of
them colonized into the germ line.
We hypothesize that the application of rbLIF and REFs
will improve the quality of rbESCs and increase our chance
in obtaining germ-line-competent rbESC lines. As the first
step to test this hypothesis, the objectives of the present work
were to: (1) establish REF feeder layer; (2) synthesize re-
combinant rbLIF; and (3) derive, maintain and characterize
rbES cell lines using REF and rbLIF.
Materials and Methods
All chemicals were purchased from Sigma Chemical Co.
(St. Louis, MO, USA), unless otherwise indicated.
Animal maintenance, hormone administration,
and embryo collection
All animal maintenance, care, and use procedures were
reviewed and approved by the University Committee on the
Use and Care of Animals (UCUCA) of the University of
Michigan. Sexually mature (6–18 months old) New Zealand
White (NZW) female rabbits were superovulated using our
routine regime (Du et al., 2009), consisting of two 0.3-mg,
two 0.4-mg, and two 0.5-mg administrations of follicle-
stimulating hormone (FSH; Folltropin-V, Bioniche Animal
Health Canada, Belleville, Ontario, Canada) at intervals of
12 h, followed by 200 IU of human choriogonadotropin
(hCG; Chorulon, Intervet Inc, Millsboro, DE, USA). Super-
ovulated does were mated with fertile males and served as
embryo donors.
Embryo collection and culture was described previously
(Lin et al., 2011). Dulbecco’s phosphate-buffered saline
(DPBS; 15240-013, Gibco, Grand Island, NY, USA) containing
0.1% polyvinyl alcohol (PVA; P-8136) was used for flushing
embryos from oviducts (PBS-PVP). Medium-199 (M-199)
with Earle’s salts, l-glutamine, 2.2 g/L sodium bicarbonate,
and 25 mM HEPES (12340-014, Gibco) supplemented with
10% fetal bovine serum (FBS; SH0070.03, Hyclone, Logan,
UT, USA) was used as the standard manipulation medium.
Zygotes were collected at 18–20 h postinsemination (hpi)
from embryo donors, and cultured in B2 medium (Labora-
tories CCD, Paris, France) supplemented with 2.5% FBS at
38.5C in 5% CO2 and humidified air. Blastocyst-stage em-
bryos were collected for ESC derivation.
Preparation of REF feeder cells
REF cells were prepared similarly as in the mouse (Roach
and McNeish, 2002). Briefly, female NZW rabbits were
mated. The fetuses were collected on 15–16 days of gestation.
This is about one-half of full gestation length. Tissues were
minced, trypsinized, and used to establish cell culture in
DMEM supplemented with 10% FBS. Rabbit embryonic fi-
broblast cell lines were established. Cells at passages 2–3
were used for establishing REF feeder cells. When these
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cultures were approximately 80% confluent, medium was
removed and replaced with culture medium supplemented
with mitomycin C (M-0503) at 10 lg/mL and incubated for
3 h. After treatment, the mitomycin C solution was removed
and cells were washed three times. To measure DNA syn-
thesis, cells were labeled with 5-bromo-2¢-deoxyuridine
(BrdU) using a commercial Kit (2750, Millipore, Billerica,
MA, USA) as described previously (Gomez et al., 2010). For
cytotoxicity, cells were labeled with a dual fluorescent stain
(calcein and ethidium homodimer-1) using a commercial kit
(L3224, Invitrogen, Carlsbad, CA, USA) to evaluate mem-
brane integrity and esterase activity, as described previously
(Gomez et al., 2010). The amounts of DNA-labeled BrdU as
well as calcein and ethidium homodimer-1 incorporation
into the cells were examined to determine the cell viability
and proliferation status of mitomycin C–treated REFs.
Synthesis of recombinant rbLIF
Sequencing rbLIF cDNA for recombinant synthe-
sis. Although the complete rbLIF cDNA sequence was not yet
available, the incomplete cDNA sequence of rbLIF was obtained
at the Ensembl website, in which 18 bp were known at the 5¢
end, followed by 159 unknown base pairs, followed by 429
known base pairs (www.ensembl.org/Oryctolagus_cuniculus/
Gene/Summary?g = ENSOCUG00000003768/). To obtain the
full-length cDNA sequence of the corresponding functional re-
gion (designated as pLIF7.2b, between brackets; Fig. 1A)
(Gearing et al., 1987; Gearing et al., 1989; Gough et al., 1988) for
recombinant synthesis of rbLIF, we designed the forward
(rbLIF-F1) and the reverse primers (rbLIF-R1) as follows: rbLIF-
F1, 5¢-ATGAAGATCTTGGCGGCA-3¢; rbLIF-R1, 5¢-TACA
CAGCCCAAGGGGAGCCGTTG-3¢.
The liver tissues from three NZW rabbits were collected
and subjected to standard total RNA extraction. The ex-
tracted RNAs were stored at - 80C prior to use. Reverse
transcriptase PCRs were performed using primers rbLIF-F1
and rbLIF-R1 and rabbit liver cDNA as template. The PCR
reaction was carried out for 35 cycles with the annealing
temperature at 55C. The PCR products of the right size were
shipped to GENEWIZ, Inc. (South Plainfield, NJ, USA) for
sequencing. Finally we compared protein sequence of rbLIF
with those of human and mouse LIF using PRALINE (Si-
mossis and Heringa 2005).
Expression and purification of recombinant rbLIF. The
functional region of rbLIF cDNA (pLIF7.2b, shown in Fig.
1A) was subcloned into the pGEX-6P-1 vector (GE Health-
care Bio-Sciences Corp., Piscataway, NJ, USA), following a
similar strategy as described previously (Gearing et al.,
1989). The recombinant rbLIF (r-rbLIF) was expressed as
fusion proteins with the 26-kDa glutathione S-transferase
(GST), separated by a thrombin-specific protease cleavage
site. The fusion product was purified on a glutathione–
agarose affinity matrix, and the r-rbLIF was released from
the matrix by cleavage with thrombin, using the GST Pur-
ification Modules (GE Healthcare Bio-Sciences Corp.). After
purification, LIF concentration was determined by enzyme-
linked immunosorbent assay (ELISA) with human LIF anti-
body (AB-250-NA, R & D Systems, Minneapolis, MN, USA),
which cross-reacts with rabbit LIF, as described previously
(Schoonjans et al., 2003).
Rabbit ES cell derivation, maintenance,
and characterization
ESC derivation and maintenance. Rabbit zygotes or
embryos (one to two celled) were cultured in vitro to blas-
tocyst (days 4–5) stage and used for ESC derivation. The base
medium (BASE) consisted of 76% knockout DMEM (10829-
018, Invitrogen), 20% FBS, 2 mM GlutaMax (35050-61,
Invitrogen), 1% nonessential amino acids, 0.1 mM b-
mercaptoethanol (444203, Millipore), and 10 ng/mL human
recombinant basic fibroblast growth factor (bFGF; 13256-029,
FIG. 1. The cDNA and suggested protein sequence of rabbit pLIF7.2b. The complete sequence of rabbit pLIF7.2b cDNA (A,
between the brackets) was cloned and sequenced to synthesize functional recombinant rbLIF. The italic and underlined
sequences are revealed by our work. The recombinant LIF protein composition suggested by the pLIF7.2b sequence (B,
between brackets) was compared with that of hLIF and mLIF, revealing higher homology between rbLIF and hLIF than
between mLIF and hLIF. In particular, rbLIF and hLIF are homologous in five (D81, H136, S137, V179, and K182) of the six critical
residues (B, indicated by arrowheads) for cross-species reactivity of LIF with LIF receptors. The only exception is at S131,
where rbLIF is homologous to mLIF (T), but different from hLIF (S).
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Invitrogen). Two culture conditions were compared for
rbESC derivation and maintenance: Condition I (MEFs +
BASE supplemented with 10 ng/mL hLIF (LIF1005, Milli-
pore) and Condition II (REFs + BASE supplemented with
10 ng/mL rbLIF). Before seeding the embryos onto mito-
mycin C–treated REFs or MEFs, the zona pellucida (ZP) of
each blastocyst was removed mechanically under an in-
verted microscope. For derivation and maintenance of
rbESCs, the cells were cultured in Condition I or Condition II
at 38C in 5% CO2 with humidified air. Five to seven days
after plating, the cell outgrowths were picked and dissoci-
ated into small clumps before reseeding onto the new feeders
in one well of a six-well plate. Passaging was performed by
incubating the ESC-like colonies with StemPro Acctutase
(A11105-01, Invitrogen) for 3 min followed by plating small
cell clumps at the cell density of 1 · 103 cells/cm2 onto new
feeders in a six-well culture dish. Passaging was performed
at 3- to 4-day intervals. For cryopreservation, dissociated
rbESCs were frozen in cryopreservation medium consisting
of 90% FBS and 10% dimethyl sulfoxide (DMSO), and stored
in liquid nitrogen tanks.
Measuring the population doubling time and colony-
forming efficiency of rbESCs. To evaluate the effects of
different combinations of LIF and feeder cells on the main-
tenance of rbESCs, we measured the population doubling
time (PD) and the colony-forming efficiency (CE) of rbESC
line R4 (passage 5) in a 2 · 3 factorial experiment (MEFs vs.
REFs, and BASE medium supplemented with 10 ng/mL
mLIF, hLIF vs. rbLIF).
PD time was calculated as PD (h) = total time/Log2 (N2/
N1) (Fang et al., 2006), where N1 is the number of seeded
cells and N2 is the number of cells after culture. A total number
of 1 · 105 rbESCs from R4 (passage 5) were seeded and cultured
under conditions according to specific experimental design.
CE was measured as described previously (Fang et al.,
2006). We seeded 1,000 cells of R4 (passage 5) in the 3-cm
culture dishes for 5 days under culture conditions according
to specific experimental design, and counted the colony
number on day 5. CE was calculated as CE = (number of
colonies/1000) · 100%.
Alkaline phosphatase staining. The rbESC cultures were
rinsed with DPBS prior to fixation in 4% paraformaldehyde
(P6148) solution. Fifteen minutes after fixation at room
temperature, rbESCs were rinsed with DPBS three times and
then stained with alkaline phosphatase (AP) solution for
30 min, as previously described (Intawicha et al., 2009). The
AP staining buffer (100 mM Tris–HCl, 100 mM NaCl, 50 mM
MgCl2, pH 9.5) consisted of 0.25 M Trizma maleate (T3128),
0.008 M MgCl2 (M-8266), 0.17 g/L Fast-Red TR salt (F8764),
and 0.4 g/L a-naphthyl phosphate (N7255). The stained cells
were observed under an inverted microscope after washing
with DPBS.
FIG. 1. (Continued).
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Immunocytochemical staining for ESC-specific mark-
ers. Immunostaining was performed to characterize ESC-
specific markers, including SSEA4, Oct4, Nanog, and Sox2.
Cells were either stained directly after washing with PBS (for
cell-surface antigen) or fixed at room temperature with 4%
paraformaldehyde for 10 min and permeated with 0.2%
Triton X-100 and 0.1% Tween in PBS for at least 30 min after
washing with PBS. Cells were then incubated with 2% goat
serum to block nonspecific binding, followed by primary
antibody (anti-Sox-2, Chemicon MAB 4343, Millipore; anti-
SSEA-4, Chemicon MAB 4304, Millipore; anti-Oct-4, Santa
Cruz, CA SC8628, Santa Cruz, CA; anti-Nanog, Abcam,
ab21603, Cambridge, MA) for 1 h. All antibodies were di-
luted in blocking solution (for Oct-4, 1:500; for SSEA-4, 1:15;
for Nanog, 1:150; for Sox-2, 1:50, R&D Systems, MAB2018)
and incubated with samples at 4C overnight after an addi-
tional three washes (15 min/wash) with 0.05% Tween-20
(Amersham Life Science, Oakville, Ontario, Canada). After
incubation with the primary antibody, the rbESCs were
washed again with DPBST three times and then incubated
with the secondary antibodies [Oct4, fluorescein iso-
thiocyanate (FITC)-conjugated rabbit antigoat immunoglob-
ulin G (IgG), 1:400, F736; Nanog, FITC-conjugated goat
antirabbit IgG, 1:300, F9887; SSEA-4, FITC-conjugated rabbit
anti-rat IgG + IgM + IgA, 1:300, Abcam ab520; Sox-2, 1:500,
Invitrogen A21202] for 40 min.
Karyotyping. Cells from selected lines (R4 and M5) at
passage 15 were subjected to karyotyping. The cells were
incubated in growth medium supplemented with 100 ng/mL
colcemid (KaryoMax Colcemid Solution, Invitrogen, 15212-
012) for 2–3 h at 38C in 5% CO2. Then, cells were trypsinized
and pelleted at 1500 rpm for 5 min, resuspended in 6 mL of
75 mM KCl, and kept in a 37C water bath for 10 min. The
cells were centrifuged and fixed in acetic acid/methanol
(vol/vol = 1:3) for 10 min. The centrifugation and fixing steps
were repeated three times. The cell pellet was resuspended in
0.5 mL of acid/methanol solution, and one drop of cell sus-
pension was dropped onto a prechilled, clean microscope
slide. The chromosomes were stained with 5% Giemsa (In-
vitrogen, 10092013) for 15 min. The chromosomes were ex-
amined at 1,000 · magnification under oil. We examined 75
metaphase spreads for Line M5 and 73 metaphase spreads
for Line R4.
In vitro differentiation of rbESCs. The putative rbESC
lines were cultured beyond passage 10 before induction of
differentiation. The rbESCs were digested with StemPro
Accutase (Invitrogen) for 3 min at 37C and plated on an
extra-low cluster plate (Corning Inc., NY, USA) for 5–7 days
to induce formation of EBs. Expression of the cell markers for
the three germ layers in EBs was assessed by RT-PCR.
RT-PCR. RT-PCR was used to detect the expression of
Oct4, Sox2, Nanog, c-Myc, Klf4, and Dppa5 for rbESCs and
Gata4, Desmin, Brachyury, Pax6, and Nestin for derived EBs.
GAPDH was used as a control of each RT-PCR. The primers
and the annealing temperature are shown in Table 1.
Rabbit ESCs and EBs derived from ESCs were collected
and subjected to RNA isolation immediately or stored in
- 20C for a few days and then subjected to RNA isolation.
Total RNA was extracted using the Qiagen RNeasy Mini Kit
(Qiagen, CA). The RNA preparations were treated with
RNase-free DNase I during preparation to remove possible
contaminating DNA. The isolated RNA was eluted with
RNase-free water and used for RT-PCR immediately.
Reverse transcription (RT) was carried out using 2.5 units
of reverse transcriptase in the presence of 1 unit of RNase
inhibitor, and 5 lM oligo(dT) or random hexamers with ap-
proximately 0.5 lg of total RNA in a final volume of 20 lL.
The solution was incubated at 42C for 15 min to generate
single-stranded cDNA. Four microliters of the RT products
from rbESCs or EBs were used in the subsequent PCR to
amplify transcripts of six pluripotent marker genes for ESCs
(Oct4, Sox2, Nanog, c-Myc, Klf4, and Dppa5) or five germ layer
marker genes for EBs (Desmin, Gata4, Nestin, Pax6, and Bra-
chyury). The glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) was amplified by RT-PCR in all RNA samples as
an internal positive control. The PCR reaction was carried
out in a total volume of 20 lL containing 10 mM Tris-HCl
(pH 8.3), 50 mM KCl, 2 mM MgCl2, 0.2 mM dNTPs, 0.2 mM
oligonucleotide primers, and 0.4 unit Taq DNA polymerase
(Invitrogen). The PCR was initiated at 95C for 2 min, fol-
lowed by 35 cycles of 30 sec at 95C, 30 sec at 57C, and 30 sec
at 72C. All RT-PCR reactions, including the appropriate
internal positive and negative controls, were repeated twice.
A volume of 10 lL PCR products was analyzed on a 1.5%
agarose gel. All PCR reactions were performed in a Hybaid
Px2 Thermal Cycler.
Table 1. Primer Sequences for RT-PCR Analysis
Gene Forward (5¢ to 3¢) Reverse (5¢ to 3¢) Product size (bp)
Oct4 CCTTCGCAGGGGGGCCTA CATGGGGGAGCCCAGAGCA 673
Sox2 CCGCTACGACGTAGCGCG CGAGCCCATGGAGCCGAGC 133
Nanog CCCAGCTGTGTGTGTGCTCAA CCAGGCTTGGGAGTACCAGG 382
c-Myc GACGCGTCCTTCTCCCCCA CTCTGGTTACCATGTCACCG 112
Klf4 CCACAGACCTGGAAAGTGGT GGAAGACGAGGATGAAGCTG 187
Dppa5 GACCTGAAAGATCCCGAGGT GTAGGAGCCGTAAACCACCA 165
Desmin AGCAGGAGATGATGGAATAC TCCAGCTTCCGGTAGG 281
Gata4 CTCAGAAGGCAGAGAGTGTG CCGCATTGCAAGAGGCCTGG 321
Nestin AGGGGGAAGAGGAAGAGGAGGAGA TGCTGCAGCCCGTTCACCACA 394
Brachyury GCTTCCCCGAGACGCAGTTCAT TGTCGGGGTAGGTTGGAGTGTTT 360
GAPDH GGAGCCAAACGGGTCATCATCC GAGGGGCCATCCACAGTCTTCT 233
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Statistical analysis
Population doubling time and colony-forming efficiency
were presented as means – standard error of the means
(SEM). Means were compared using the General Linear
Model (SPSS 11.0, Chicago, US). Statistical significance was
considered when a p value was less than 0.05.
Results
Synthesis of recombinant rabbit LIF protein
We first obtained the cDNA sequence necessary for the
synthesis of functional rbLIF. This region was reportedly used
for the synthesis of functional recombinant human and murine
LIF (Gearing et al., 1987; Gough et al., 1988). The sequence is
shown in Fig. 1A and designated as pLIF7.2b (between
brackets). The italic and underlined sequences were revealed by
our work and were validated by three biological repeats.
A comparison of the recombinant LIF protein composition
suggested by the pLIF7.2b sequence with those of the hLIF
and mLIF revealed that rbLIF is 83.2% homologous with
hLIF, which is higher than that of hLIF with mLIF (74.2%)
and that of rbLIF with mLIF (75.3%).
There are six residues (D81, S131, H136, S137, V179, K182; Fig.
1B, indicated by arrows) that are reportedly critical for the
cross species binding of hLIF and mLIF receptor (Layton
et al., 1994). We compared these six residues among hLIF,
rbLIF, and mLIF. Interestingly, rbLIF and hLIF share the
same code in 5 (D81, H136, S137, V179, and K182) out of these six
residues (83.3%). The only exception is at S131 residue of
hLIF: the corresponding residue of rbLIF and mLIF is T.
We introduced the functional region rbLIF (pLIF7.2b ) into
pGEX-6P-1 vector between restriction sites BamHI and NotI
and selected colony #3 for the expression after confirming the
size (542 bp) (Fig. 2A) and sequence. Both the total input
protein (before purification) and the purified fusion protein
(before thrombin cleavage) were found to be positive after
western blotting by anti-human LIF antibody at a molecular
weight of 46 kDa, but not at 19 kDa (Fig. 2B). After thrombin
cleavage, the rbLIF was identified by western blotting with
the anti-human LIF antibody, at a similar molecular weight
(19 kDa) to human LIF (Fig. 2B).
Validation of REF feeder cell preparation
After mitomycin C treatment (3 h), REF cell viability was
evaluated by the Calcein AM assay, and the proliferation
status was evaluated by the BrdU assay. Approximately 95%
of cells were of green fluorescent (Fig. 3A,B) after the calcein
AM assay, indicating satisfactory viability of REF cells.
Ninety-four percent of the cells stopped dividing, as indi-
cated by the BrdU assay (Fig. 3C,D). These results clearly
demonstrated that our feeder cell preparation protocol was
working well on REF cells. MEF cells were prepared and
validated similarly.
Establishment of rbES cell lines with Conditions I and II
A total of 123 blastocysts (representative images shown in
Fig. 3E) were used for rbESC derivation (Table 2). Because
our original hypothesis was that the LIF and feeder cells
from the same origin (REF + rbLIF, Condition II) would im-
prove the germ-line transmission efficiency of the derived
FIG. 2. Production of recombinant rbLIF. (A) The functional region of rbLIF was introduced into pGEX-6P-1 vector. Colony
#3 was selected for the expression of recombinant protein after confirming the size and sequence. (B) The GST–rbLIF fusion
protein was identified after western blotting by anti-human LIF antibody at a molecular weight of 46 kDa (upper arrow) in
both the total input protein (before purification) and the purified fusion protein (before thrombin cleavage). After thrombin
cleavage, the r-rbLIF was found at the similar molecular weight (19 kDa, lower arrow) with human LIF (positive control).
Input and fusion proteins did not show signals at 19-kDa size.
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rbES cell lines, we assigned 37 blastocysts (30%) to Condition
I, and 86 blastocysts (70%) to Condition II.
A total of 72 ICMs were picked (Table 2). The ICM-pick
efficiency was similar between Condition I and Condition II:
23 ICMs (M1-M23) for Condition I (23/37, 62.2%) and 49
ICMs (R1-R49) for Condition II (49/86, 57.0%) (Table 2).
A similar efficiency of putative rbESC derivation was
obtained between Condition I and Condition II (Table 2).
Two putative rbESC lines (M5 and M23) were derived from
Condition I (2/23, 8.7%). Five putative rbESC lines (R4, R9,
R15, R21, and R31) were derived from Condition II (5/49,
10.2%). The overall efficiency was 9.7% (7/72). The mor-
phology of putative rbES cell lines derived on Condition II
(e.g., R4, Fig. 3H) appeared similar to that of the ones derived
on Condition I (e.g., M5, Fig. 3G).
Effects of LIF and feeder cell origins
on the maintenance of rbESCs
We examined the effects of LIF origin and feeder cell or-
igin in a 2 · 3 factorial experiment (REF vs. MEF and BASE
medium supplemented with 10 ng/mL hLIF, mLIF vs. rbLIF;
Tables 3 and 4). We examined the PD time and CE of the
putative rbESC line R4 (passage 5) under these conditions.
Our results demonstrated that the origin of LIF and feeder
cells affected the rbESC maintenance, as measured by PD
and CE. When mouse feeder cells were used, line R4 grew
slower with rbLIF (PD, 27.04 h; CE, 3.84%) than with hLIF
(PD, 15.28 h; CE, 10.80%) or mLIF (PD, 15.06 h; CE, 14.80%)
(Tables 3 and 4). When rabbit feeder cells were used, the PD
and CE of line R4 were normal, regardless of the origin of LIF
(PD, 12.72–14.02 h; CE, 7.20–12.48%) (Tables 3 and 4).
The two conditions we used to derive rbESC lines (Con-
dition I, MEF + hLIF; Condition II, REF + rbLIF) appeared to
support satisfactory rbESC growth in vitro, with similar PD
and CE values to those previously reported in rabbits (Fang
et al., 2006). In Condition I, the PD time was 15.28 h and the
CE was 10.80%. In Condition II, the PD time was 14.00 h and
the CE was 12.48%. The rbESCs appeared to grow faster than
human ESC and induced pluripotential cells (iPSCs), as the
PDs are shorter and the CEs are higher of our rbESCs com-
paring to those reported for human ESC or iPSCs (PD, 43.2–
47.8 h; CE, 0.24–0.83%) (Amit et al., 2000; Fang et al., 2006;
Takahashi et al., 2007).
Typical pluripotency marker expressions of rbESCs
derived and cultured in Conditions I and II
All five putative rbESC lines (R4, passage 7; R9, passage 6;
R15, passage 4; R21, passage 5; R31, passage 4) derived on
Condition II expressed AP (representative image shown in
Fig. 4A, top panel). They expressed Oct-4, Nanog, Sox-2, and
FIG. 3. Evaluation of REF cells and derivation of rbES cells on REF cells. REF cells were treated with mitomycin-C, followed
by calcein AM assay to evaluate their viability and BrdU assay to evaluate their proliferation status. In the calcein AM assay,
the presence of light fluorescence indicated viable cells (A), which correlated well with the 4¢,6-diamidino-2-phenylindole
(DAPI) staining of the same population (B), indicating that almost all cells were still viable. In the BrdU assay, non-mitomycin
C–treated REF cells consisted of a large population of dividing cells (dark staining) (C), whereas most mitomycin C–treated
cells stopped proliferating, showing no dark staining (D). After seeding blastocysts (E) on the mitomycin C–treated REF cells
(F), several putative cell lines were successfully derived and maintained (line R4, passage 10, H), displaying a similar ESC
morphology with rbESCs derived and maintained on MEF cells (line M5, passage 10, G). Scale bars, 200 lm.
Table 2. Derivation Efficiencies of rbESC Lines with Blastocysts Developed
from Different Culture Conditions
Treatment Total no. of embryos No. ICM attached (%) No. putative ESC lines (%)
Condition I (MEFs + hLIF) 37 23 (62.2) 2 (8.7)
Condition II (REFs + rbLIF) 86 49 (57.0) 5 (10.2)
Sum 123 72 (58.5) 7 (9.7)
rbESC, rabbit embryonic stem cells; ICM, inner cell mass; MEF, mouse embryonic fibroblasts; hLIF, human leukemia inhibitory factor; REF,
rabbit embryonic fibroblasts.
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SSEA-4 as determined by immunochemistry staining (rep-
resentative images shown in Fig. 4A, lower panels). These
rbESC lines also expressed pluoripotent genes, such as Oct-4,
Sox-2, Nanog, C-Myc, Klf4, and Dppa5 (Fig. 4B), as determined
by RT-PCR assays. More variance in the expression levels of
Nanog and Sox-2 among different cell lines was observed
comparing to other genes examined (Fig. 4B). Lines R21 and
R31 showed lower expression levels of Nanog than lines R4,
R9, and R15, whereas lines R4 and R15 expressed higher
levels of Sox2 than the other three lines (R9, R21, and R31).
The expression levels of other genes examined (Oct-4, C-Myc,
Klf4, Dppa5, and GAPDH) appeared to be similar among
different lines.
Both putative rbESC lines derived on Condition I (M5, P6
and M23, P4) were also positive for AP, Oct-4, Nanog, Sox-2,
and SSEA-4 staining, and expressed pluoripotent genes, in-
cluding Oct-4, Sox-2, Nanog, C-Myc, Klf4, and Dppa5 (images
not shown).
Rabbit ESCs derived and cultured under Conditions I
and II maintained normal karyotypes
Selected rbESC lines (M5 representing Condition I, and R4
representing Condition II) were subjected to karyotyping
analysis. Seventy-three metaphase spreads of R4 cells (pas-
sage 15) and 75 metaphase spreads of M5 cells (passage 15)
were counted. There were 60% of M5 and 57.5% of R4
spreads showing normal rabbit karyotype with 44 chromo-
somes (Fig. 4C). Both R4 (Fig. 4D,E) and M5 were found to be
male cell lines.
Rabbit ESCs derived on Conditions I and II were
capable of differentiating into three germ layers in vitro
Putative rbESC lines derived on Condition I (M5, P12 and
M23, P11) or Condition II (R4, P10; R9, P12; R15, P11; R21,
P10 and R31, P10) all formed EBs in the presence of serum in
suspension culture (representative image shown in Fig. 5A).
RT-PCR results showed that EBs derived from these cell lines
expressed the marker genes for all three germ layers (Gata4
for endoderm, Desmin and Brachyury for mesoderm, Nestin
and Pax6 for ectoderm), but not the pluripotent gene Oct-4
(representative images shown in Fig. 5B). Higher gene ex-
pression levels were found for endoderm-specific genes (e.g.,
Gata4) and ectoderm genes (e.g., Nestin and Pax6) than for
mesoderm-specific genes (e.g., Desmin and Brachyury).
Discussion
In the present work, we derived rbESC lines using ho-
mologous LIF and feeder cells. The use of REFs as feeder cells
has been attempted by Graves and Moreadith (Graves and
Moreadith, 1993). They harvested day-16 rabbit fetuses and
established REF feeders. However, they found that REFs
promoted differentiation of putative rbESCs into a spindle-
shaped cell type that did not passage. Hamster embryonic
fibroblasts also promoted differentiation of putative hamster
ESCs in an early study (Doetschman et al., 1988). Recently,
homologous feeder cells were reported to support the deri-
vation and culture of human, monkey, buffalo, and cat ESCs,
in addition to mESCs (Anand et al., 2011; Gomez et al., 2010;
Li et al., 2005; Richards et al., 2002). For example, hESCs can
now also be established and maintained on human embryonic
fibroblasts, adult fallopian tube epithelia, or foreskin fibro-
blasts (Hovatta et al., 2003; Richards et al., 2002). The use of
homologous feeder cells is particularly important for hESCs to
avoid animal contaminations. On animal ESCs, the applica-
tion of homologous feeder cells would similarly avoid cross-
species contamination. More importantly, it may provide an
environment to improve the quality of the ESCs, which may
consequently enhance the chance of germ-line transmission, a
major goal of animal ESC research and application. It is sug-
gested that cell-surface and soluble factors required to support
ESC self-renewal in an undifferentiated status are species-
specific (Gomez et al., 2010), and LIF has been shown to have
different cross-species reactivity (Owczarek et al., 1997).
In the present study, we found that rbESC lines derived
and maintained on REFs displayed similar morphologies
and characteristics as the ones derived and maintained on
MEF feeders. We did not observe a higher percentage of cells
differentiating on the REFs as compared to those on the
MEFs. This improvement over the earlier study (Graves and
Moreadith, 1993) may come from the overall quality im-
provement on media and reagents used for processing the
feeder cells and for the ESC derivation and culture, as well as
the optimized protocols. For example, GlutaMax was used in
the present study instead of L-glutamine. Knockout DMEM,
a medium optimized for growth of undifferentiated ESCs, is
now available and was used in the present study. Notably,
we used higher concentrations of FBS (20% vs. 15%) and
nonessential amino acids (1% vs. 0.5%) in the ESC culture
medium as compared to the Graves et al. report. We also
note that there is a need to establish drug resistant REF
feeders, which will be essential for gene targeting in rbESCs.
Table 3. Population Doubling (PD) Time
of Putative Rabbit ESC Line R4 (Passage 5)
with Different Feeders and LIF Supplementation
hLIF (h) mLIF (h) rbLIF (h)
REFs 12.72 – 0.76a 14.02 – 1.74a 14.00 – 0.72a
MEFs 15.28 – 2.95a 15.06 – 2.81a 27.04 – 1.87b
a,bNumbers with different superscripts differ significantly. The PD
time was in normal range under both conditions I (hLIF + MEFs,
15.28 h) and II (rbLIF + REFs, 14.00 h); however, the PD time was
abnormally long under the rbLIF + MEFs condition (27.04 h).
ESC, embryonic stem cells; LIF, leukemia inhibitory factor; h,
human; m, mouse; rb, rabbit; REFs, rabbit embryonic fibroblasts;
MEFs, mouse embryonic fibroblasts.
Table 4. Colony-Forming Efficiency (CE%)
of Putative Rabbit ESC Line R4 (Passage 5)
with Different Feeders and LIF Supplementation
hLIF mLIF rbLIF
REFs 12.40 – 1.48a 7.20 – 3.04ab 12.48 – 0.64a
MEFs 10.80 – 1.17a 14.80 – 1.00a 3.84 – 1.61b
a,bNumbers with different superscripts differ significantly. The
CE% was in a normal range under both conditions I (hLIF + MEFs,
10.80%) and II (rbLIF + REFs, 12.48%); however, the CE% was
abnormally low under the rbLIF + MEFs condition (3.84 h).
ESC, embryonic stem cells; LIF, leukemia inhibitory factor; h,
human; m, mouse; rb, rabbit; REFs, rabbit embryonic fibroblasts;
MEFs, mouse embryonic fibroblasts.
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Recombinant mouse and human LIF have been synthe-
sized in the Escherichia coli system (Gearing et al., 1987;
Gearing et al., 1989; Gough et al., 1988). We used a similar
strategy and synthesized recombinant rbLIF in E. coli. LIF
derived from E. coli exhibited identical biological potency as
mammalian LIF or LIF derived from yeast (Gough et al.,
1988; Hilton et al., 1988). At the same concentration (10 ng/
mL), our homemade recombinant rbLIF and commercially
purchased hLIF supported the derivation and maintenance
of rbESC lines with similar efficiencies. This is not surprising
considering the fact that hLIF and rbLIF are almost identical
in the binding sites that are critical for cross-species reac-
tivity. Previous studies in mLIF and hLIF found that mLIF
cannot bind to hLIF receptor (hLIF-R), whereas hLIF binds to
mLIF receptor (mLIF-R) with a much higher affinity. How-
ever, replacing six residues in mLIF with those from hLIF
would enable mLIF to bind hLIF-R, confirming the critical
roles of these six amino acids for the binding specificity
across species (Layton et al., 1994). The present work re-
vealed that rbLIF and hLIF are identical in five of these six
sites, suggesting hLIF and rbLIF may be interchangeable in
in vitro experiments. Interestingly, rbLIF was found benefi-
cial in deriving mESCs in certain strains such as C57BL/6N
(Schoonjans et al., 2003). Similar efficiency of ESC derivation
(34% vs. 38%) was reported between basic ESC culture me-
dium supplemented with mLIF (1000 IU/mL) or rbLIF
(10 ng/mL), whereas much higher efficiency (61%) was
achieved when the basic culture medium was conditioned by
a rabbit fibroblast cell line transduced with genomic rbLIF
(15 ng/mL) (Schoonjans et al., 2003). Moreover, this
FIG. 4. Specific ESC markers, gene expression, and karyotyping results of putative rbESCs derived and maintained under
Condition II. Putative rbESC lines (R4, R9, R15, R21, and R31) derived and maintained under Condition II (REF + rbLIF) are
positive for AP (A, top panel) and other pluripotency markers, including Oct-4, Nanog, Sox2, and SSEA4 (B, lower panels).
(A) Representative staining images of R4 (passage 7). RT-PCR assays revealed that these cell lines (R4, passage 7; R9, passage
6; R15, passage 4; R21, passage 5; and R31, passage 4) expressed pluripotency genes such as Oct-4, Sox-2, Nanog, c-Myc, Klf4,
and Dppa5 (B). GAPDH was used as the internal control. Karyotyping analysis on line R4 (passage 15) and line M5 (passage
15) revealed 57.5% and 60.0% normal ploidy rates, respectively (C). Both R4 (D and E) and M5 (images not shown) were
identified as male cell lines. Scale bars, 200 lm.
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approach of using culture medium conditioned with geno-
mic rbLIF (instead of mLIF) resulted in successful establish-
ment of germ-line-competent ESC lines from several
presumed ‘‘nonpermissive’’ inbred mouse strains (Schoon-
jans et al., 2003). We also found that the recombinant rbLIF
supported the maintenance of mESC lines (data not shown).
These results suggested that the recombinant rbLIF may be
also useful for ESC studies in species other than rabbits.
LIF signaling pathway is central in maintaining mESCs
(Smith et al., 1988), but not hESCs (Thomson et al., 1998). The
LIF-dependence of rbESCs is not clear yet. In the present
work, supplementation hLIF (in Condition I) or rbLIF (in
Condition II) in the medium is necessary for rbESC deriva-
tion and maintenance, consistent with some previous reports
(Hsieh et al., 2011; Intawicha et al., 2009), but not several
others (Fang et al., 2006; Honda et al., 2009; Wang et al.,
2005). In our work, upon withdrawing hLIF or rbLIF from
the culture medium, rbESCs quickly undergo spontaneous
differentiation (data not shown). The requirement for exog-
enous LIF may indicate the low expression levels of LIF by
the feeder cells in our work. If the feeder cells can express
sufficient amount of LIF, the requirement for exogenous LIF
may become unnecessary, which could explain why LIF was
not supplemented in several rbESC reports (Fang et al., 2006;
Honda et al., 2009; Wang et al., 2005). In mouse ESC studies,
it is reported that when feeder cells expressed high levels of
LIF, exogenous LIF becomes unnecessary (Feng et al., 2009).
The optimal concentration of rbLIF for promoting rbESC
derivation and further passage to maintain pluripotency is
under investigation.
The present work demonstrated that the combination of
REF and rbLIF is able to support the derivation and main-
tenance of rbESC lines in a similar manner as MEFs and hLIF
did. Interestingly, the combination of rbLIF and MEFs did
not support the culture of rbESC line R4 well, demonstrated
by long PD time and low CE, whereas other combinations of
feeder cells and LIF were able to maintain this cell line in
normal growth. We do not know the molecular mechanisms
leading to such interaction effects between rbLIF and MEF
on the rbESC culture yet, but careful attention should be paid
when using this combination for rbESC culture.
FIG. 4. (Continued).
FIG. 5. In vitro differentiation of rbESC line R4. Rabbit ESC
line R4 (passage 10) was used for EB formation (A, upper
panel, D0). When these cells were cultured in specialized
nonadherent dishes, we observed EB formation starting at
D1. The number and the size of the EBs continued to increase
throughout EB culture (A, lower panel, D5). The EBs ex-
pressed all three primary germ layer markers (Gata4 for en-
doderm, Desmin and Brachyury for mesoderm, Nestin and
Pax6 for ectoderm), but not the pluripotency gene Oct4 (B).
GAPDH was used as the internal control. Scale bars, 200 lm.
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In the present work, bFGF was supplemented to both
Condition I and Condition II. In fact, we were not successful
in deriving putative rbESC lines without the supplemen-
tation of bFGF (data not shown). The FGF pathway plays
important role for derivation and maintenance of rbESCs: it
promotes rbESC self-renewal and prevents differentiation.
Absence of FGF results in slow growth and quick differ-
entiation (Fang et al., 2006; Hsieh et al., 2011; Wang et al.,
2008; Wang et al., 2007). Mitogen-activated protein kinase/
extracellular signal-regulated kinase (MAPK/ERK) and
phosphatidylinositol-3-kinase (PI3K)/AKT pathways, both
of which are downstream of the FGF pathway, are required
for maintaining rbESCs in an undifferentiated state. Such a
requirement is different from that in mice and rats. In these
two species, the activation of FGF pathway promotes dif-
ferentiation (Buehr et al., 2008; Li et al., 2008), whereas the
use of the 3i medium, two of the three inhibiting the
FGF pathway, resulted in germ-line-transmitting ESCs.
Recently, it was proposed that FGF-dependent ESCs, in-
cluding most human ESC lines, are actually ‘‘primed’’-state
ESCs and have little chance transmitting to the germ cells
(Blair et al., 2011).
Therefore, it is possible that the rbESCs derived in the
present study, as well as all other reported rbESC lines, are
also primed-state stem cells. To capture the naı̈ve state rather
than primed-state rbESCs, it may be worth exploring the use
of earlier-stage preimplantation embryos. We used day-4 to
day-5 blastocysts in the present work. Many embryos were
already at the expanded or even the hatched stage. Because
the naı̈ve-state and primed-state ESCs may very likely come
from cells at two different embryo stages—the pre- and the
postimplantation epiblast (Blair et al., 2011)—we speculate
that the use of earlier-stage embryos (e.g., days 3–4) may
eliminate the dependency of rbESCs on bFGF and derive
more naı̈ve-state ESCs.
The long-term goal of the present study is to derive germ-
line-competent rbESCs for the production of gene-targeted
transgenic rabbits. To date, only mouse and rat ESCs have
been proven to be germ-line transmissible and are used to
produce gene-targeted transgenic animals via the ESC in-
jection approach. Nuclear transfer, in combination with
gene targeting in somatic cells, has been used as an alter-
native to produce gene-targeted pigs, cattle, sheep, and
goats. Unfortunately, the rabbit has been proven to be an
extremely difficult species to clone (Du et al., 2009). Since
the first report of successful rabbit cloning a decade ago
(Chesne et al., 2002), no gene-targeted transgenic rabbits
were produced via this approach. Using REFs and rbLIF in
the present study, we obtained satisfactory efficiency in
rbESC derivation and are satisfied with the quality of these
cell lines, as confirmed by immunochemistry staining, gene
expression assays, and in vitro differentiation assays. The
PD and CE of rbESCs derived in Condition II are similar to
those reported previously (Fang et al., 2006). One cell line
(R4) is now at over 25 passages and still displays typical
rbESC morphology and maintains normal ploidy (data not
shown). These results clearly demonstrate that homologous
feeder cells and LIF are able to support the derivation and
culture of rbESCs; however, we cannot conclude whether or
not they are better than feeder cells and LIFs that are of
foreign species origin in improving the totipotency of these
cells. Future work regarding ESC injection and embryo
transfer is required to test whether or not the ESCs derived
on homologous feeder cells and LIF are more competent for
germ-line transmission.
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